BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2025
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals Limited held its 82nd AGM on August 25, 2025 via Video Conferencing. All four resolutions were approved by shareholders with the requisite majority. The resolutions included adoption of audited standalone and consolidated financial statements, re-appointment of Mrs. Minoshi Maheshwari (DIN: 01575975) as a director liable to retire by rotation, and appointment of secretarial auditors. Out of 55,207,500 total outstanding shares, 38,538,720 shares (69.81%) were polled through remote e-voting and e-voting during the AGM. All resolutions received nearly 100% support, with negligible dissent (25 to 1,722 votes against across resolutions). Promoters holding 36,431,770 shares voted entirely in favor of all resolutions. A total of 14,983 shareholders were on the cut-off date, with 60 shareholders (3 promoters and 57 public) attending the meeting via VC.
This is a routine post-AGM regulatory filing confirming that all standard resolutions (financial statements adoption, director re-appointment, and auditor appointment) were passed with overwhelming shareholder support. No material impact on the stock is expected from this disclosure.